🔗 Share this article

Chancellor Reeves has stated she is preparing "focused measures to deal with cost of living issues" in the upcoming Budget.

During an interview with the BBC, she emphasized that lowering inflation is a shared task of both the government and the Bank of England.

The United Kingdom's price growth is projected to be the most elevated among the Group of Seven advanced economies this year and next.

Potential Energy Cost Interventions

Reports indicate the administration could intervene to bring down utility costs, for instance by cutting the present 5% rate of VAT applied on energy.

A further approach is to reduce some of the regulatory levies currently included in bills.

Budgetary Limitations and Expert Predictions

The administration will obtain the next draft from the official forecaster, the OBR, on Monday, which will show how much space there is for such actions.

The view from the majority of analysts is that the Chancellor will have to declare tax increases or spending cuts in order to meet her declared fiscal targets.

Previously on the same day, estimates suggested there was a £22bn deficit for the Treasury chief to address, which is at the more modest range of projections.

"There's a shared task between the central bank and the administration to further reduce some of the sources of price increases," Reeves stated to reporters in Washington, at the annual meetings of the IMF and global financial institution.

Tax Commitments and Global Issues

While much of the attention has been on expected tax increases, the Treasury chief said the latest information from the OBR had not altered her commitment to election pledges not to increase rates on earnings tax, VAT or National Insurance.

She attributed an "uncertain global environment" with increasing international and commercial issues for the fiscal tax moves, likely to be targeted on those "with the broadest shoulders."

Global Trade Tensions

Referring to worries about the UK's trade ties with China she said: "The UK's security interests always come first."

Recent declaration by China to increase trade restrictions on critical minerals and other resources that are essential for high-technology manufacturing led American leader the US President to threaten an extra 100% import tax on goods from China, increasing the risk of an full-scale trade war between the two global powers.

The American finance chief labeled the Chinese action "economic coercion" and "a global supply chain control attempt."

Asked about accepting the US offer to join its battle with China, the Chancellor said she was "deeply worried" by China's actions and encouraged the Beijing authorities "not to put up barriers and restrict access."

She said the move was "harmful for the international commerce and generates further obstacles."

"I believe there are areas where we should address Chinese policies, but there are also significant opportunities to export to Chinese markets, including financial services and other sectors of the economy. We've got to get that equilibrium correct."

The Treasury chief also stated she was collaborating with G7 counterparts "regarding our own essential resources plan, so that we are reduced dependence."

NHS Medicine Pricing and Funding

The Chancellor also admitted that the price the National Health Service pays for pharmaceuticals could increase as a result of ongoing negotiations with the US government and its pharmaceutical firms, in exchange for lower tariffs and capital.

Some of the world's largest drug companies have said recently that they are either halting or scrapping investments in the United Kingdom, with some attributing the low prices they are receiving.

Recently, the government science advisor said the cost the NHS pays for drugs would need to increase to prevent firms and pharmaceutical investment departing from the United Kingdom.

The Chancellor told the BBC: "We have seen because of the pricing regime, that medical research, new drugs have not been available in the United Kingdom in the extent that they are in other European countries."

"The objective is to ensure that patients getting treatment from the NHS are able to receive the finest essential medicines in the globe. And so we are examining these issues, and... seeking to attract more funding into the UK."